Forte Biosciences (FBRX) EBT Margin (2017 - 2019)
Forte Biosciences' (FBRX) quarterly EBT Margin came in at 117588.89% in Q4 2019, up 9812222.0% year-on-year from N/an in Q4 2018, and up 43.51% on a QoQ basis from 208166.67% in Q3 2019.
Forte Biosciences (FBRX) EBT Margin (2017 - 2019) Analysis & Trends
Forte Biosciences (FBRX) has 3 years of EBT Margin data on file, last reported at 117588.89% in Q4 2019.
- On a quarterly basis, EBT Margin rose 9812222.0% year-over-year to 117588.89% in Q4 2019; TTM through Dec 2019 was 131472.22%, a 13121021.0% decrease from a year earlier, with the FY2019 full-year figure at 176430.56%, down 17616855.0% from the prior year.
- EBT Margin for Q4 2019 stood at 117588.89%, up from 208166.67% in the prior quarter.
- Over the last five years, EBT Margin for FBRX reached as high as 6.25% in Q3 2018 and fell as low as 215711.11% in Q4 2018.
- Historically, EBT Margin has averaged 126955.59% across 3 years, with a median of 125140.0% in 2017.
- On a YoY basis, EBT Margin climbed as much as 16845556 bps in 2019 and fell as far as 20817292 bps in 2019.
- Year by year, EBT Margin stood at 108370.0% in 2017, then plunged by 99 bps to 215711.11% in 2018, then soared by 45 bps to 117588.89% in 2019.
- Per Business Quant data, the three most recent EBT Margin figures were 117588.89% in Q4 2019, 208166.67% in Q3 2019, and 10311.11% in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Forte Biosciences | 174.08 Mn | 115.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -117,588.89% |
| Sep 30, 2019 | -208,166.67% |
| Jun 30, 2019 | -10,311.11% |
| Mar 31, 2019 | -189,822.22% |
| Dec 31, 2018 | -215,711.11% |
| Sep 30, 2018 | 6.25% |
| Jun 30, 2018 | -178,766.67% |
| Mar 31, 2018 | -143,111.11% |
| Dec 31, 2017 | -108,370.00% |
| Sep 30, 2017 | -99,530.00% |
| Jun 30, 2017 | -125,140.00% |